Immunai raises $60M as it expands from improving immune therapies to discovering new ones, too [TechCrunch]
Just three years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total
Read moreJust three years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total
Read more